2021 中国台湾指南建议:COPD的治疗(更新版)

2021-06-28 中国呼吸科专家组(统称) J Formos Med Assoc

慢性阻塞性肺疾病在全世界范围内的发病率和死亡率都占有重要地位,早期疾病症状不易区分,导致诊断和干预率较低,近期,中国台湾COPD的治疗指南更新,主要内容涉及COPD的诊断、评估、监测以及管理等。

中文标题:

2021 中国台湾指南建议:COPD的治疗(更新版)

英文标题:

Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations

发布日期:

2021-06-28

简要介绍:

慢性阻塞性肺疾病(COPD)在全世界范围内的发病率和死亡率都占有重要地位,早期疾病症状不易区分,导致诊断和干预率较低,近期,中国台湾COPD的治疗指南更新,主要内容涉及COPD的诊断、评估、监测以及管理等。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 中国台湾指南建议:COPD的治疗(更新版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=59e411c002211a69, title=2021 中国台湾指南建议:COPD的治疗(更新版), enTitle=Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations, guiderFrom=J Formos Med Assoc, authorId=0, author=, summary=慢性阻塞性肺疾病在全世界范围内的发病率和死亡率都占有重要地位,早期疾病症状不易区分,导致诊断和干预率较低,近期,中国台湾COPD的治疗指南更新,主要内容涉及COPD的诊断、评估、监测以及管理等。, cover=https://img.medsci.cn/20211016/1634393588516_5579292.jpg, journalId=0, articlesId=null, associationId=745, associationName=中国呼吸科专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Jun 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">慢性阻塞性肺疾病(COPD)在全世界范围内的发病率和死亡率都占有重要地位,早期疾病症状不易区分,导致诊断和干预率较低,近期,中国台湾COPD的治疗指南更新,主要内容涉及COPD的诊断、评估、监测以及管理等。</span></p>, tagList=[TagDto(tagId=295, tagName=COPD)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=295, guiderKeyword=COPD, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2738, appHits=147, showAppHits=0, pcHits=1192, showPcHits=2589, likes=0, shares=6, comments=4, approvalStatus=1, publishedTime=Sun Oct 17 22:15:30 CST 2021, publishedTimeString=2021-06-28, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Sun Oct 17 22:14:55 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 17:12:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 中国台湾指南建议:COPD的治疗(更新版).pdf)])
2021 中国台湾指南建议:COPD的治疗(更新版).pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1186778, encodeId=c5511186e7856, content=👌🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4015391287, createdName=ms9000000945627336, createdTime=Fri Jan 21 12:27:26 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063554, encodeId=e3e210635544b, content=中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44315646525, createdName=天空蓝天白云, createdTime=Sun Oct 24 21:00:07 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063221, encodeId=171210632218d, content=没有中文版……, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37715594134, createdName=ms3000001502159385, createdTime=Sat Oct 23 19:47:56 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
    2022-01-21 ms9000000945627336

    👌🏻

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1186778, encodeId=c5511186e7856, content=👌🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4015391287, createdName=ms9000000945627336, createdTime=Fri Jan 21 12:27:26 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063554, encodeId=e3e210635544b, content=中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44315646525, createdName=天空蓝天白云, createdTime=Sun Oct 24 21:00:07 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063221, encodeId=171210632218d, content=没有中文版……, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37715594134, createdName=ms3000001502159385, createdTime=Sat Oct 23 19:47:56 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
    2021-10-24 天空蓝天白云

    中文

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1186778, encodeId=c5511186e7856, content=👌🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4015391287, createdName=ms9000000945627336, createdTime=Fri Jan 21 12:27:26 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063554, encodeId=e3e210635544b, content=中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44315646525, createdName=天空蓝天白云, createdTime=Sun Oct 24 21:00:07 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063221, encodeId=171210632218d, content=没有中文版……, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37715594134, createdName=ms3000001502159385, createdTime=Sat Oct 23 19:47:56 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
    2021-10-23 ms3000001502159385

    没有中文版……

    0

拓展阅读

2010 GOLD 慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2010-01-01

2010JRS 日本呼吸学会慢性阻塞性肺疾病(COPD)诊治指南(概述)

日本呼吸学会(JRS,the Japanese Respiratory Society) · 2010-02-01

2011 GOLD 慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2011-12-01

2013 GOLD 慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略(修订版)

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2013-02-13

2013 西班牙COPD指南:慢性阻塞性肺疾病基于临床表型的分级和治疗

西班牙肺病和胸外科学会(SEPAR,Spanish Society of Pneumology and Thoracic Surgery) · 2013-03-20